effects of stopping glp-1 medication In recent years, medications have transformed obesity treatment, producing unprecedented amounts weight loss in clinical trials. But they come with an important challenge... What happens when people stop taking them? The GLP-1 Agonists and Obesity:

Consequently, it is essential to prioritize shared decision-making and individualized risk-benefit assessments for prescribing GLP-1 RAs, while avoiding misuse with off-label indications

Incretins also slow down the digestion of food so that glucose from your meals takes longer to be absorbed, and they can reduce your appetite and result in weight loss

1, 2026, the company said it will no longer cover GLP-1 medications for weight loss for employers with fewer than 100 employees

The end result is a chance to maximize the health benefits of GLP-1 obesity treatments (which have enormous potential) while containing risks and costs through data-driven insights

And along with that is muscle mass